COMPANY

Cardiosense

HQ: Chicago, IL source · cardiosense.com ↗ · Midwest

Keywords: wearable

Location: Chicago, IL · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $26.14M (Form D filed Aug 24, 2026). SEC Form D 0001957335-26-000003 (Aug 24, 2026)
Evidence (1 event)
- Aug 24, 2026 · SEC Form D 0001957335-26-000003
  Name of Issuer: Cardiosense, Inc.; CIK: 1957335; Address: Chicago, IL; Submission type: D; Filing date: 2026-08-24; Industry Group: Other Health Care; Date of First Sale: 2026-08-07; Types of Securities Offered: Equity, Security to be acquired, Other (Convertible Promissory Notes have converted into equity in connection with this transaction); Business combination transaction: false; Total Offering Amount: 42012230; Total Amount Sold: 26137050; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

May 22, 2026 FDA FDA De Novo grant: PCWP Analysis Software — DEN250057, May 22, 2026. Applicant at approval: Cardiosense, Inc. source ↗
Jul 22, 2025 FDA FDA 510(k) clearance: CardioTag — K243566, Jul 22, 2025. Applicant at approval: Cardiosense, Inc. source ↗

May 22, 2026 FDA De Novo grant: PCWP Analysis Software — DEN250057, May 22, 2026. Applicant at approval: Cardiosense, Inc. source ↗
Jul 22, 2025 FDA 510(k) clearance: CardioTag — K243566, Jul 22, 2025. Applicant at approval: Cardiosense, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12